IDSI PhD student Will Baskett crunched EHR data, finding only a few long-haul symptoms directly related to COVID in comparison to generic viral infection

In a new study, a team of University of Missouri researchers made an unexpected discovery: people experiencing long-lasting effects from COVID-19 — known as “long COVID” or post-COVID conditions — are susceptible to developing only seven health symptoms for up to a year following the infection. They are: fast-beating heart, hair loss, fatigue, chest pain,

Two IDSI Core Faculty Elected as Fellow of AAAS

Dr. Xiu-Feng “Henry” Wan and Dr. Xiaoqin Zou were named as Fellows of the American Association for the Advancement of Science. Read More

MUIDSI Dissertation Defense: IDENTIFICATION OF IMMUNE-RELATED GENE SIGNATURES TO EVALUATE IMMUNOTHARAPEUTIC RESPONSE IN CANCER PATIENTS USING EXPLORATORY SUBGROUP DISCOVERY

Phenotypic and genotypic heterogeneity are characteristic features of cancer patients. To tackle patients’ heterogeneity, immune checkpoint inhibitors (ICIs) represent one of the most promising therapeutic approaches. However, approximately 50% of cancer patients that are eligible for treatment with ICIs will not respond well, which motivates the exploration of immunotherapy in combination with either targeted treatments

MUIDSI DISSERTATION DEFENSE: Explainable Artificial Intelligence To Stratify Pan-Cancer Patients For Immune Checkpoint Inhibitor Decision Making

Immune checkpoints are a normal part of the immune system. It engages when proteins on the surface of immune cells called T cells recognize and bind to partner proteins on other cells, such as some tumor cells. Immune based therapies such as ICIs work by blocking checkpoint proteins from binding with their partner proteins. This

2022 Mizzou Faculty Alumni Awards – Notable Presence from MUIDSI

The 67th Annual Faculty Alumni Awardees were announced on July 20, 2022. Dr. Chi-Ren Shyu, MU IDSI Director; Dr. Lori Popejoy, MU IDSI Core Faculty and Interim Dean of Sinclair School of Nursing; and Dr. Dr. Stevan Whitt, Senior Associate Dean for Clinical Affairs of Medicine and MU IDSI’s long term physician collaborator, were among the

Dr. Popejoy leads MU Sinclair School of Nursing as Interim Dean

Click to read more.

Dr. Blake Meyers Elected to the National Academy of Sciences

Dr. Blake Meyers, MUIDSI Informatics PhD program Core Faculty and Professor in the Division of Plant Science and Technology, and jointly appointed as a Principal Investigator and Member of the Donald Danforth Plant Science Center, has been elected as a Member of the US National Academy of Sciences. https://www.danforthcenter.org/news/blake-meyers-elected-to-national-academy-of-sciences/

AMIA Informatics Summit Best Student Paper Award

By Karly Balslew On March 21st, doctoral student Humayera Islam won the American Medical Informatics Association (AMIA) Student Paper Competition award for the 2022 AMIA Informatics Summit that was held in Chicago. “It’s one of the biggest platforms for informatics people,” Islam said. “It’s very a very diverse and multidisciplinary platform where anybody that works

MUIDSI Online Data Science and Analytics Program Ranked #7 in Fortune Magazine

The MS Data Science and Analytics (DSA) Program of the MU Institute for Data Science and Informatics (MUIDSI) was recently ranked the 7th best online master’s degree in Data Science Programs in 2022 by Fortune magazine. The rankings were composed of a selectivity score and a demand score. The selectivity score made up 85% of the ranking which

Harnessing the power of AI to advance knowledge of Type 1 diabetes

An interdisciplinary team of researchers from the University of Missouri, Children’s Mercy Kansas City and Texas Children’s Hospital has used a new data-driven approach to learn more about persons with Type 1 diabetes, who account for about 5-10% of all diabetes diagnoses. The team gathered its information through health informatics and applied artificial intelligence (AI)

News